IRAK1 and IRAK4 Inhibitors for the Treatment of Lower-Risk MDS

News
Video

Dr Brunner presents updated data on the treatment of lower-risk MDS with IRAK1/IRAK4 inhibitors.

Related Videos
Carrie L. Kitko, MD
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Lori A. Leslie, MD
Video 18 - "Reflecting on Differentiated Thyroid Cancer: Final Insights"
Video 17 - "Phase 2 ATLEP Trial Results"
Naseema Gangat, MBBS
Ashwin Kishtagari, MD
Somedeb Ball, MBBS
A panel of 5 experts on lung cancer